Is Intravitreal Bevacizumab an Effective Treatment Option for Nonarteritic Anterior Ischemic Optic Neuropathy
Journal of Neuro-Ophthalmology, 06/18/2012
Clinical Article
Prescott CR et al. – The results are consistent with the natural course of the disease, and bevacizumab did not appear to have a dramatic effect on the clinical outcome in this small series of patients with nonarteritic anterior ischemic optic neuropathy.



